Insulin Therapy of Nondiabetic Septic Patients Is Predicted by para-Tyrosine/Phenylalanine Ratio and by Hydroxyl Radical-Derived Products of Phenylalanine
Details
The content you want to view is only available to Zendy Plus users.Already have an account? Click here. to sign in.